Glutamate receptors and cognitive behavioral therapy for insomnia
Part of Brain & nervous system, Mental health clinical trials.
This study tests how a brain receptor called mGluR5 affects sleep and depression treatment. You may qualify if you have major depression with insomnia and are not currently on antidepressants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have major depression that is currently active
- You score at least 29 on a depression severity questionnaire
- You are at least 18 years old and in good physical health
- You are not taking any antidepressant medications right now
- You have not had drug or alcohol dependence in the last 6 months
- You are not a smoker (no nicotine use for at least 1 year)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, non-invasive brain stimulation method (called kTMP) to see if it can improve anhedonia, which is the loss of interest or pleasure in things you used to enjoy. It is for people with depression who have significant anhedonia.
This study tests two methods of targeting repetitive transcranial magnetic stimulation (TMS) for depression: one using brain imaging to guide the treatment, and the other using a standard scalp measurement. The goal is to see if imaging-guided TMS works better for people with treatment-resistant depression.
This trial tests a new type of brain stimulation called theta-burst stimulation to see if it helps treat depression. It is for people aged 18-50 who are currently experiencing a major depressive episode and are on a stable antidepressant regimen.
This trial looks at how a specific brain receptor related to pain signals (nociceptin/orphanin FQ receptor) may be involved in depression. It may help researchers understand depression better by comparing people with current versus past (remitted) major depression.
This study uses brain-signal targeting (likely with MRI) to see whether it can improve certain symptoms of depression. You may be able to join if you’re 18–65 and currently have a depressive episode, and if you can safely complete the scan.
This study uses brain imaging (PET scans) to understand depression in people with Parkinson's disease. It may also test a depression treatment called ketamine, but the main goal is to see how the brain changes with depression.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.